Back
Jasper Therapeutics 10K Form
Sell
43
JSPR
Jasper Therapeutics
Last Price:
22.80
Seasonality Move:
53.84%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive JSPR News And Ratings
See the #1 stock for the next 7 days that we like better than JSPR
JSPR Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-11.84M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.64 |
| Price / Book: | 3.6 |
Profitability
| EPS (TTM): | -18.60000 |
|---|---|
| Net Income (TTM): | $-62.44M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Jasper Therapeutics Earnings Forecast
Key Jasper Therapeutics Financial Ratios
- Per Share Earnings over the last 4 years have been positive in 1 years.
Jasper Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | JSPR |
| Website: | jaspertherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
JSPR Technical Analysis vs Fundamental Analysis
Sell
43
Jasper Therapeutics (JSPR)
is a Sell
Is Jasper Therapeutics a Buy or a Sell?
-
Jasper Therapeutics stock is rated a Sell
The current Jasper Therapeutics [JSPR] share price is $23.93. The Score for JSPR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.